↓ Read PDF
01 · ABSTRACT

Abstract

Purpose: Historically, highly sophisticated medical linear accelerators (linacs) frequently experience significant additional operational failures in low- and lower-middle-income countries (LMICs) than in high-income countries (HICs). This study focuses on LMICs in Africa where there is a substantial equipment shortfall, projected to be a gap by 2040 of about 5000 linacs. The purpose of this study was to gain an insight into the poor performance of linac components, the unreliable infrastructure often encountered in LMICs and the consequent linac-related treatment downtime.

Methods and Materials: A questionnaire to obtain information on linac performance and repair experiences was sent to at least one cancer center in each of the 28 African countries that had experience treating cancer patients with linacs at the time of the survey (4 more countries have acquired linacs since we completed this survey). For comparison, questionnaires were also sent to selected facilities in four high-income countries (Canada, Switzerland, UK, US) and to Jordan, a middle-income country.

To investigate factors influencing linac downtime, we first utilised flow diagrams to illustrate the dependence of linac subsystem performance on infrastructural/environmental factors, the availability of spare parts and local repair capability. Secondly, a univariate analysis correlated linac downtime with factors such as method of linac fault diagnosis and staffing. Finally, a multivariate analysis investigated the relationship between Gross Domestic Product (GDP) per capita and cancer mortality to incidence ratio statistics and compared these with the surveyed linac downtime across low-, middle- and high-income countries.

Results: Responses to the survey confirmed significant multi-factorial issues that influence the extent of linac downtime especially the performance of multi-leaf collimators, electron guns, vacuum systems, RF power and software. Other challenges include electrical power instability, inadequate national funding (GDP/capita), and workforce capability as well as a significant shortfall in formal education and training programmes for the radiation therapy (RT) workforce.

Conclusion: This survey identified numerous modes of RT equipment failure causing treatment downtime in LMICs that can be overcome by improvements in the design of RT technology but they need to be accompanied by increased RT staff training, improved broadband access and increased annual national funding for RT. The collaborative network of linac-based RT facilities in 28*African countries that was developed to conduct this study is available for further investigations as RT capacity and capability improve in Africa.

 

 

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 12 No 8 (2024): Vol 12 No 8 (2024): August ISSUE, Issue 8, VOl.12
SectionResearch Articles
Published31 August 2024
DOI10.18103/mra.v12i8.5530
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

Authors & affiliations

MD

Manjit Dosanjh

University of Oxford, Oxford, UK; CERN, Geneva, Switzerland; International Cancer Expert Corps, Washington, DC., USA

TI

Taofeeq A. Ige

ITAR Project,University of Lancaster, Lancaster, UK;  National Hospital Abuja, Nigeria

JB

Joseph Bateman

University of Oxford, Oxford, UK

AJ

Alexander Jenkins

University of Oxford, Oxford, UK; ITAR Project, University of Lancaster, Lancaster, UK

DK

Deepa Angal- Kalinin

ITAR Project,University of Lancaster, Lancaster, UK; STFC Daresbury Laboratory, Warrington, UK; Lancaster University, Lancaster, UK

PM

Peter McIntosh

ITAR Project,University of Lancaster, Lancaster, UK; STFC Daresbury Laboratory, Warrington, UK

CC

C. Norman Coleman

International Cancer Expert Corps, Washington, DC., USA

DO

Donna O’Brien

International Cancer Expert Corps, Washington, DC., USA

DP

David Pistenmaa

International Cancer Expert Corps, Washington, DC., USA

EW

Eugenia Wendling

International Cancer Expert Corps, Washington, DC., USA

SK

Saad Khoudri

Ismail Zergoug, CAC (Anti Cancer Centre), Setif, CAC Oran, Algeria

HE

Higidio Miezi Eduardo

Instituto Angolano de Controlo de Câncer, Luanda, Angola

SG

Surbhi Grover

Princess Marina Hospital, Gaborone, Botswana; University of Pennsylvania, USA

RM

Remigio Makufa

Memory Nsingo, Life Gaborone Private Hospital, Gaborone, Botswana

AM

Anne Marthe Maison Mayeh

Hopital General du Douala, Douala, Cameroon

SN

Samba Richard Ndi

NRPA, Yaounde, Apolinaire Ngnah, Cameroon Oncology Center, Douala, Cameroon

TO

Tofangui Alain Ouattara

Centre for Medical Oncology and Radiotherapy, Cocody, Cote D’Ivoire

EA

Ehab Attalla

Nashaat Deiab, Tarek Shouman, National Cancer Institute (NCI), Cairo, Egypt

KE

Khaled El-Shahat

Al-Azhar University, Cairo, Egypt

EB

Eskadmas Yinesu Belay

Black Lion Specialized Hospital, Addis Ababa, Ethiopia

RK

Rolland Kayende

Institut de Cancerologie de Libreville (ICL), Libreville, Gabon

GA

George Felix Acquah

Emmanuel Amankwaa-Frempong, Sweden Ghana Medical Center, Accra, Ghana

HF

Hubert Foy

AFRCSIS, Accra, Ghana

FH

Francis Hasford

RAMSRI-GAEC, Accra, S.N. Tagoe, Korle-Bu Teaching Hospital, Accra, Ghana

EA

Eric K. T. Addison

Komfo Anokye Teaching Hospital, Kumasi, Ghana

EN

Ejidio Ngigi

Kenyatta National Hospital, Nairobi, Kenya

FB

Fadwa Badi

Tripoli Cancer Hospital, Tripoli, Libya

FE

Fairoze El Tashani

Ihab Elburi, National Cancer Center Benghazi, Libya

TH

Tovo Harivony

Jean Norbert Randriamarolahy, CHU-HJRA, Ampefiloha, Antananarivo, Madagascar

AK

Aphousalle Kone

Siaka Maiga, Drissa Samake, Mali Radiation Oncology Centre, Bamako, Mali

MC

Moussa Cheibetta

Ahmedou Tolba, Centre National d'Oncologie-Nouakchott-Mauritanie, Mauritania

SM

Seeven Mootoosamy

Victoria Hospital, Quatre Bornes, Candos, Mauritius

SB

Salwa Boutayeb

INO (National Oncology Institute), Rabat, Morocco

AM

Ainadine Momade

Central Hospital of Maputo, Maputo, Mozambique

MG

Melanie Grobler

The Namibian Oncology Center, Windhoek, Namibia

WM

Wilfred Midzi

Dr A. B. May Cancer Centre, Windhoek Central Hospital, Windhoek, Namibia

SA

Simeon Chinedu Aruah

National Hospital, Abuja, Nigeria

HI

Hassan Ibrahim

UDUTH, Sokoto, Nigeria

KN

Kenneth Nwankwo

UNTH, Enugu, Nigeria

JK

Joel Kra

Pacifique Mugenzi, Radiotherapy Center, Military Hospital, Kigali, Rwanda

MD

Magatte Diagne

Hopital Universitaire le Dantec, Institut Curie, Dakar, Senegal

GL

Graeme Lazarus

IALCH, Durban, South Africa

AR

Ayron Rule

Eastern Cape Health, Port Elizabeth, South Africa

CT

Chris Trauernicht

Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa

FE

Fawzia Elbashir

National Cancer Institute, Gezira University, Sudan

WM

Wad Madani

Nadir Abd Ellatif Ali, Radiation & Isotopes Center Khartoum (RICK), Sudan

HM

Hellen Makwani

Shaid Yusufu, Ocean Road Cancer Institute (ORCI) - Dar es Salaam, Tanzania

LF

Leila Farhat

Centre Hospitalier Universitaire, Habib Bourguiba Sfax, Tunisia

MB

Mounir Besbes

Institut de Salah Azaiez, Tunis, Tunisia

KA

Kavuma Awusi

Uganda Cancer Institute, Kampala, Uganda

MK

Mutule Mulape Kanduza

Barbara Mule, Nasangu Augustine Mwale, Cancer Diseases Hospital, Lusaka, Zambia

GA

Godfrey Azangwe

National University of Science and Technology, Bulawayo, Zimbabwe

LM

Lawrence Mhatiwa

Oncocare Cancer Treatment Centre, Harare, Zimbabwe

EM

Edwin Mhukayesango

Parirenyatwa Radiotherapy Centre, Harare, Zimbabwe

JK

Jamal Khader

King Hussein Cancer Center, Amman, Jordan

SF

Santo Filice

Centre d'oncologie Dr. Léon-Richard, Moncton, New Brunswick, Canada

GC

Gordon Chan

Juravinski Cancer Center, Hamilton, Ontario, Canada

SB

Stephen Breen

Daniel Letourneau, Odette Cancer Center, Toronto, Ontario, Canada

RW

Rebecca Wong

Princess Margaret Cancer Center, Toronto, Ontario, Canada

IY

Ivan Yeung

Southlake Regional Health Centre, Ontario, Canada

JB

Jacques Bernier

Shelley Bulling, Oscar Matzinger, Genolier Clinic, Geneva, Switzerland

AA

Ajay Aggarwal

Michael Pearson, Winston Swaby, Guy’s and St Thomas’ NHS Foundation, London, UK

AA

Ajay Aggarwal

Michael Pearson, Winston Swaby, Guy’s and St Thomas’ NHS Foundation, London, UK

RA

Robert Apsimon

David Cheneler, Lancaster University, Engineering Department, Lancaster, UK

FV

Frank van den Heuvel

Oxford University Hospitals NHS Foundation Trust, Oxford, UK

JV

Jose Eduardo Villareal-Barajas

Joseph Bateman1, Royal Devon and Exeter Hospital, Devon, UK

NT

Natalie Thorp

Royal Preston Hospital, Preston, UK

RH

Richard Hugtenburg

South West Wales Cancer Centre, Singleton Hospital, Swansea, UK

BM

Boris Militsyn

Trevor Hartnett, UKRI/STFC Daresbury Laboratory, Daresbury, Warrington, UK

EK

Eric Klein

David Wazer, Lifespan Health System/Warren Alpert Medical School of Brown University, USA

SR

Scot Remick

Stephen Ryan, Maine Medical Center, Portland, ME, USA

DP

Daniel Petereit

Marvin Glass, Monument Health/Avera Health System – Rapid City, SD, USA

HB

Harmar D. Brereton

Christopher A. Peters, Northeast Radiation Oncology Centers, Scranton, PA, USA

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗